Cytokinetics Inc (NAS:CYTK)
$ 48.3 -0.68 (-1.39%) Market Cap: 5.06 Bil Enterprise Value: 5.20 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 43/100

Cytokinetics Inc Annual Shareholders Meeting Transcript

May 10, 2023 / 05:00PM GMT
Release Date Price: $39.23 (+1.00%)
Operator

Welcome, ladies and gentlemen, to the Cytokinetics 2023 Annual Stockholders Meeting. At this time, I would like to inform you that this meeting is being recorded (Operator Instructions)

I will now turn the meeting over to John Henderson, the Chairman of Cytokinetics' Board of Directors. Please go ahead.

John Tannahill Henderson
Cytokinetics, Incorporated - Independent Chairman

Welcome, ladies and gentlemen. I'm John Henderson, the Chairman of the Cytokinetics Board of Directors, and I welcome you to our 2022 Annual Meeting of Stockholders. I call the meeting to order. John Faurescu, Associate General Counsel and Corporate Secretary, will record the minutes. Before proceeding to the formal business, let me introduce Robert Blum, the company's President and Chief Executive Officer, who will provide a review of our 2022 accomplishments and plans for 2023 after our formal proceedings. Before proceeding, though, I'm pleased to introduce the members of Cytokinetics' Board of Directors who are here with us today: Muna Bhanji, Sandy Costa, Sandy Smith,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot